scleroderma
SCLERODERMA
Scleroderma is a connective tissue disorder characterized by skin thickening and fibrosis. It is rare, autoimmune and chronic.
It has an idiopathic cause and not contagious.
Early microvascular damage, mononuclear cell infiltrates and slowly developing fibrosis are the important features of the tissue lesions.
The leading causes of death are pulmonary fibrosis and pulmonary arterial hypertension.

Scleroderma Patient Education

Patient Education

  • An exercise program designed by a physiotherapist is most crucial
    • To reduce contractures and functional impairment
    • To minimize joint deformities
    • To keep the blood freely flowing
  • Rest if joints become inflamed
  • Skin care is very important to keep a good supply of blood flowing to the skin
    • Keep the whole body warm to help open the blood vessels of the skin, especially in the hands and feet
    • Avoid strong detergents or other substances that can irritate the skin
    • Prevent drying of skin
    • Use moisturizers to soften and protect the skin
  • Cosmetic makeup may be used to cover up lesions
    • Inactive lesions with atrophic changes may be managed with injectable cosmetic fillers, injection of autologous fat transplantation or surgical excision
  • Avoid high doses of vitamin C (>1000 mg) as it promotes collagen formation
  • Avoid emotional stress as it reduces blood flow
  • Quit smoking
  • Minimize caffeine intake
  • Avoid sympathomimetic decongestant medications (eg Pseudoephedrine)
  • Avoid high-dose corticosteroid use (>15 mg of Prednisone daily) if possible
  • Check blood pressure regularly to monitor for possible complications
Editor's Recommendations
Most Read Articles
Stephen Padilla, 5 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
5 days ago
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Jairia Dela Cruz, 18 hours ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.